FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Pulls Biosimilar Analytical Similarity Guidance

FDA pulls for further consideration a draft guidance on statistical approaches to evaluate analytical similarity between a biosimilar and a reference ...

Medical Devices

Tenon Medical Sacroiliac Joint Fixation System Cleared

FDA clears a Tenon Medical 510(k) for the Catamaran Sacroiliac Joint Fixation System, indicated for sacroiliac joint fusion for conditions including j...

Human Drugs

FDA Denies Petitions, Approves Nocdurna

FDA approves a Ferring NDA for Nocdurna and denies two petitions asking it not to approve such an NDA.

Medical Devices

FDA Approves Senseonics Eversense Glucose Monitor

FDA approves the Senseonics Eversense continue glucose monitor that uses an implanted sensor to continuously measure glucose levels.

Human Drugs

Purdue Promoted Pseudoaddiction to Defend Oxycontin: CBS

CBS Evening News reports a former Purdue Pharma sales persons claim that the company falsely used pseudoaddiction to minimize the harm blockbuster Oxy...

Human Drugs

FDA Lifts Staar Surgical Warning Letter

FDA issues Staar Surgical a close-out letter that lifts a Warning Letter dated 5/21/2014, a signal that the company has corrected all issues to the ag...

Human Drugs

PDUFA Waiver, Reduction, Refund Guidance

FDA announces availability of a revised draft guidance on drug user fee waivers, reductions, and refunds.

Human Drugs

Court Orders Eagle Bendeka Orphan Exclusivity

The DC federal court orders FDA to grant Eagle Pharmaceuticals orphan drug exclusivity for its cancer drug Bendeka.

Medical Devices

2 Theranos Execs Indicted on Wire Fraud Charges

A federal grand jury indicts the Theranos founder and former chief operating officer on wire fraud charges following an FDA investigation.

Federal Register

Info Collection Extension for Adverse Event Reporting

Federal Register notice: FDA seeks comments on an information collection extension for its Guidance for Industry: Adverse Event Reporting for Outsourc...